tradingkey.logo
๎™

Intelligent Bio Solutions Inc

INBS
6.140USD
-0.850-12.16%
์ข…๊ฐ€ย 12/19, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
55.86M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

Intelligent Bio Solutions Inc

6.140
-0.850-12.16%

์ž์„ธํ•œ ๋‚ด์šฉ์€ Intelligent Bio Solutions Inc ํšŒ์‚ฌ

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ INBS
ํšŒ์‚ฌ ์ด๋ฆ„Intelligent Bio Solutions Inc
์ƒ์žฅ์ผDec 23, 2020
CEOSimeonidis (Harry)
์ง์› ์ˆ˜16
์œ ํ˜•Ordinary Share
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒDec 23
์ฃผ์†Œ135 W 41St St,
๋„์‹œNEW YORK
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†ŒNASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐ€United States of America
์šฐํŽธ ๋ฒˆํ˜ธ10036
์ „ํ™”16467905756
์›น์‚ฌ์ดํŠธhttps://ibs.inc/
์ข…๋ชฉ ์ฝ”๋“œ INBS
์ƒ์žฅ์ผDec 23, 2020
CEOSimeonidis (Harry)

Intelligent Bio Solutions Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--

์ˆ˜์ต ๋ถ„์„

ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Oct 6
ํ†ตํ™”: USD๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์ง€์—ญ๋ณ„USD
์ด๋ฆ„
์ˆ˜์ต
๋น„์œจ
United Kingdom
2.87M
93.96%
Rest of world
132.70K
4.35%
Australia
29.17K
0.96%
Americas
22.64K
0.74%
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Nov 15
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sat, Nov 15
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
๊ธฐํƒ€
86.34%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
๊ธฐํƒ€
86.34%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Hedge Fund
11.51%
Investment Advisor
1.33%
Individual Investor
0.99%
Investment Advisor/Hedge Fund
0.61%
Research Firm
0.14%
๊ธฐํƒ€
85.42%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Oct 1
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Oct 1
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
2023Q2
43
60.27K
19.45%
+30.17K
๋” ๋ณด๊ธฐ

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
Alyeska Investment Group, L.P.
613.89K
6.76%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
15.48K
0.17%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
51.45K
0.57%
+2.44K
+4.98%
Jun 30, 2025
Sakiris (Spiro Kevin)
53.93K
0.59%
--
--
Sep 11, 2025
Simeonidis (Harry)
40.41K
0.45%
--
--
Sep 11, 2025
Goldman Sachs & Company, Inc.
12.83K
0.14%
+10.00
+0.08%
Jun 30, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
์ด๋ฆ„
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
Dec 12, 2025
Merger
10โ†’1
Jan 25, 2024
Merger
12โ†’1
Jan 25, 2024
Merger
12โ†’1
Jan 25, 2024
Merger
12โ†’1
Jan 25, 2024
Merger
12โ†’1
Feb 09, 2023
Merger
20โ†’1
๋‚ ์งœ
์œ ํ˜•
๋น„์œจ
Dec 12, 2025
Merger
10โ†’1
Jan 25, 2024
Merger
12โ†’1
Jan 25, 2024
Merger
12โ†’1
Jan 25, 2024
Merger
12โ†’1
Jan 25, 2024
Merger
12โ†’1
Feb 09, 2023
Merger
20โ†’1
Feb 09, 2023
Merger
20โ†’1
Feb 09, 2023
Merger
20โ†’1
Feb 09, 2023
Merger
20โ†’1

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Intelligent Bio Solutions Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋ˆ„๊ตฌ์ธ๊ฐ€์š”?

๎™Œ
Intelligent Bio Solutions Inc์˜ ์ƒ์œ„ 5๋Œ€ ์ฃผ์ฃผ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์Šต๋‹ˆ๋‹ค:
Alyeska Investment Group, L.P.๋Š” 613.89K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 6.76%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
The Vanguard Group, Inc.๋Š” 15.48K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 0.17%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Geode Capital Management, L.L.C.๋Š” 51.45K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 0.57%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Sakiris (Spiro Kevin)๋Š” 53.93K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 0.59%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.
Simeonidis (Harry)๋Š” 40.41K์ฃผ์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•˜๊ณ  ์žˆ์œผ๋ฉฐ, ์ „์ฒด ์ฃผ์‹์˜ 0.45%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค.

Intelligent Bio Solutions Inc์˜ ์ƒ์œ„ 3๋Œ€ ์ฃผ์ฃผ ์œ ํ˜•์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
Intelligent Bio Solutions Inc์˜ ์ฃผ์š” ์ฃผ์ฃผ ์œ ํ˜• ์ƒ์œ„ 3๊ฐ€์ง€๋Š”
Alyeska Investment Group, L.P.
Adar1 Capital Management LLC
The Vanguard Group, Inc.์ž…๋‹ˆ๋‹ค.

Intelligent Bio Solutions Inc(INBS)์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ๋ช‡ ๊ฐœ์ž…๋‹ˆ๊นŒ?

๎™Œ
2025Q3 ๊ธฐ์ค€์œผ๋กœ, Intelligent Bio Solutions Inc์˜ ์ฃผ์‹์„ ๋ณด์œ ํ•œ ๊ธฐ๊ด€์€ ์ด 31๊ณณ์ด๋ฉฐ, ์ด๋“ค์ด ๋ณด์œ ํ•œ ์ฃผ์‹์˜ ์ด ๊ฐ€์น˜๋Š” ์•ฝ 799.23K๋กœ ์ „์ฒด ๋ฐœํ–‰ ์ฃผ์‹์˜ 8.80%๋ฅผ ์ฐจ์ง€ํ•ฉ๋‹ˆ๋‹ค. ์ด๋Š” 2025Q2 ๋Œ€๋น„ -2.45% ์ฆ๊ฐ€ํ•œ ์ˆ˜์น˜์ž…๋‹ˆ๋‹ค.

Intelligent Bio Solutions Inc์˜ ์ตœ๋Œ€ ์ˆ˜์ต์›์€ ๋ฌด์—‡์ธ๊ฐ€์š”?

๎™Œ
FY2025 ๊ธฐ์ค€, Intelligent Bio Solutions Inc์˜ -- ๋ถ€๋ฌธ์ด ๊ฐ€์žฅ ๋†’์€ ๋งค์ถœ์„ ๊ธฐ๋กํ–ˆ์œผ๋ฉฐ, ๊ธˆ์•ก์€ --๋กœ ์ „์ฒด ๋งค์ถœ์˜ --%๋ฅผ ์ฐจ์ง€ํ–ˆ์Šต๋‹ˆ๋‹ค.
KeyAI
๎™